Artesunate Protects LPS-Induced Acute Lung Injury by Inhibiting TLR4 Expression and Inducing Nrf2 Activation
- 549 Downloads
Artesunate, a derivative of artemisinin, has been reported to have anti-inflammatory property. However, few studies showed the protective effects of artesunate on lung injury. In this study, we aimed to investigate the effects of artesunate on LPS-induced lung injury in mice. The mice were treated with artesunate 1 h before or after LPS treatment. The effects of artesunate on lung MPO activity and malondialdehyde (MDA) content were detected. The lung wet/dry radio and the numbers of inflammatory cells in BALF were also measured. ELISA was used to evaluate the levels of TNF-α, IL-1β, and IL-6 in BALF. Western blot analysis was adapted to detect TLR4 and Nrf2 signaling pathways. The results showed that artesunate protected against LPS-induced ALI by decreasing the numbers of inflammatory cells, lung edema, MPO activity, and MDA content. Furthermore, artesunate significantly inhibited the levels of TNF-α, IL-1β, and IL-6. Artesunate also inhibited LPS-induced IL-6 and IL-8 production in the A549 cells. In addition, artesunate dose-dependently suppressed LPS-induced TLR4 expression and NF-κB activation. The expression of Nrf2 and HO-1 were also up-regulated by artesunate. The data suggest that artesunate possesses anti-inflammatory and anti-oxidant properties against LPS-induced ALI via inhibiting TLR4 signaling pathway and activating Nrf2 signaling pathway.
KEY WORDSartesunate LPS lung injury Nrf2 HO-1
Compliance with Ethical Standards
Conflict of Interest
The authors declare that they have no conflict of interest.
- 7.Seki, H., K. Fukunaga, M. Arita, H. Arai, H. Nakanishi, R. Taguchi, T. Miyasho, R. Takamiya, K. Asano, A. Ishizaka, et al. 2010. The anti-inflammatory and proresolving mediator resolvin E1 protects mice from bacterial pneumonia and acute lung injury. Journal of Immunology 184: 836–843.CrossRefGoogle Scholar
- 9.Wang, D., J. Shi, S. Lv, W. Xu, J. Li, W. Ge, C. Xiao, D. Geng, and Y. Liu. 2015. Artesunate attenuates lipopolysaccharide-stimulated proinflammatory responses by suppressing TLR4, MyD88 expression, and NF-kappaB activation in microglial cells. Inflammation 38: 1925–1932.CrossRefPubMedGoogle Scholar
- 10.Lai, L.N., Y.X. Chen, X.X. Tian, X.J. Li, X.J. Zhang, J.W. Lei, Y.H. Bi, B.W. Fang, and X.L. Song. 2015. Artesunate alleviates hepatic fibrosis induced by multiple pathogenic factors and inflammation through the inhibition of LPS/TLR4/NF-kappa B signaling pathway in rats. European Journal of Pharmacology 765: 234–241.CrossRefPubMedGoogle Scholar
- 19.Fitzgerald, K.A., D.C. Rowe, B.J. Barnes, D.R. Caffrey, A. Visintin, E. Latz, B. Monks, P.M. Pitha, and D.T. Golenbock. 2003. LPS-TLR4 signaling to IRF-3/7 and NF-kappaB involves the toll adapters TRAM and TRIF. Journal of Experimental Medicine 198: 1043–1055.CrossRefPubMedPubMedCentralGoogle Scholar
- 22.Gonzalez, P.K., J. Zhuang, S.R. Doctrow, B. Malfroy, P.F. Benson, M.J. Menconi, and M.P. Fink. 1996. Role of oxidant stress in the adult respiratory distress syndrome: evaluation of a novel antioxidant strategy in a porcine model of endotoxin-induced acute lung injury. Shock 6(Suppl 1): S23–S26.CrossRefPubMedGoogle Scholar
- 25.Chen, X.L., G. Dodd, S. Thomas, X. Zhang, M.A. Wasserman, B.H. Rovin, and C. Kunsch. 2006. Activation of Nrf2/ARE pathway protects endothelial cells from oxidant injury and inhibits inflammatory gene expression. American Journal of Physiology - Heart and Circulatory Physiology 290: H1862–H1870.CrossRefPubMedGoogle Scholar
- 26.Ueda, K., T. Ueyama, K.I. Yoshida, H. Kimura, T. Ito, Y. Shimizu, M. Oka, Y. Tsuruo, and M. Ichinose. 2008. Adaptive HNE-Nrf2-HO-1 pathway against oxidative stress is associated with acute gastric mucosal lesions. American Journal of Physiology-Gastrointestinal and Liver Physiology 295: G460–G469.CrossRefPubMedGoogle Scholar